Quality control tests for vaccines in leprosy vaccine trial, Avadi

Area of Science:

• Immunology
• Microbiology
• Vaccinology

Background:

• Leprosy remains a significant public health concern, necessitating effective vaccines.
• Large-scale clinical trials require rigorously tested vaccine preparations.

Purpose of the Study:

• To perform comprehensive quality control on vaccine batches used in a large-scale comparative leprosy vaccine trial.
• To ensure the safety, sterility, and efficacy of candidate leprosy vaccines and control preparations.

Main Methods:

• Vaccine batches underwent quality control testing by suppliers according to WHO protocols for killed Mycobacterium leprae.
• Bacille Calmette-Guerin (BCG) vaccine quality control was performed at the BCG Vaccine Laboratory.
• Toxicity, sterility, bacterial count, and protein estimation tests were conducted on all vaccine lots.

Main Results:

• All tested vaccine preparations, including ICRC bacilli, BCG plus killed M. leprae, BCG, and normal saline, passed quality control.
• Bacterial content and protein concentration were consistent with original preparations.
• Vaccines were confirmed to be free from microorganisms and toxic materials, demonstrating safety for human use.

Conclusions:

• The quality control assessments confirmed the satisfactory quality of all leprosy vaccine preparations.
• The tested vaccines met all required safety and efficacy standards for the large-scale clinical trial.